NAD vs NMN: What’s the Difference?
.webp)

When it comes to NAD vs NMN, what sets them apart? Read this article to learn more, including their benefits, safety, and effectiveness.
- When it comes to NAD vs NMN, NMN is a precursor to NAD+. Your body converts NMN into NAD+ inside cells, which is why NMN is commonly used in oral supplements.
- Oral NAD+ may face absorption challenges. Because NAD+ is a larger molecule, it may be broken down during digestion, while smaller precursors (such as NMN and NR) are generally considered more practical for oral use.
- Research shows NMN may increase blood NAD+ markers.
- NMN is not an anti-aging cure. While NAD+ levels decline with age, NMN supplements are not approved to prevent, treat, or reverse aging or any disease.
- Quality and medical guidance are important when taking any new supplement. If you’re considering NMN or other NAD+ options, look for third-party testing and speak with a licensed healthcare provider to determine what’s appropriate for you.
The information in this article is intended for educational purposes only. The following information is not meant to diagnose or treat any condition. Individual responses may vary; always consult a licensed healthcare provider regarding your specific health situation.
.webp)
If you’ve been looking into longevity or cellular health supplements, you’ve probably seen both NAD and NMN mentioned. They’re closely related, but they’re not the same thing.
What’s NAD?
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell. It plays a role in:
- Cellular energy production
- Mitochondrial function
- Metabolic processes
- DNA repair pathways
- Enzyme activation (including sirtuins and PARPs)
Simply put, NAD+ helps cells convert nutrients into usable energy.
However, research has shown that NAD+ levels tend to decline with age. Scientists are still working to fully understand the implications of this decline, but lower NAD+ levels have been associated with changes in energy metabolism and cellular resilience.
What’s NMN?
NMN (nicotinamide mononucleotide) is a precursor to NAD+.
Your body naturally produces NMN as part of the “salvage pathway,” which is one of the main routes cells use to maintain NAD+ levels. Inside the cell, NMN is converted into NAD+ through a single enzymatic step.
Interestingly, NAD is nearly twice the size of NMN. This size difference is one reason NMN is often discussed as a potential oral precursor to NAD+.
In fact, NAD+ faces several biological hurdles that may limit the effectiveness of oral supplementation. For one, it can be broken down in the digestive tract before absorption. Additionally, because NAD+ is relatively large and carries a net negative charge from its two phosphate groups, it doesn’t easily cross cell membranes intact.
Current evidence suggests it must first be converted into smaller, less charged molecules before cells can utilize it. For this reason, NAD+ is sometimes administered intravenously in certain clinical settings under medical supervision.
For everyday supplementation, however, researchers have focused more on precursors such as NMN and NR (nicotinamide riboside), which are smaller and easier for the body to process.
{{primary-cta}}
What Does the Research Say About NMN?
In terms of NAD benefits, most studies focus on precursors, such as NMN. While human research on NMN is still emerging, several small clinical trials have explored its safety and biological effects. Here’s what has been observed in controlled settings:
NAD+ Level Changes
Some trials have shown that NMN supplementation may increase blood NAD+ metabolites over several weeks. Doses studied in humans have typically ranged from 250 mg to 900 mg daily.
While increases in blood markers are measurable, it’s important to note that blood NAD+ levels do not automatically translate to specific health outcomes. More long-term research is needed to understand broader effects.
Physical Function and Performance
Some trials in middle-aged and older adults have explored physical performance outcomes. In certain studies, participants taking NMN demonstrated improvements in walking distance or aerobic capacity compared to placebo groups.
However, these studies were relatively small, and results should be interpreted cautiously. NMN is not approved to treat or prevent any condition, and it should not be viewed as a performance-enhancing therapy.
Metabolic Markers
Preliminary research has examined NMN’s effects on insulin sensitivity and metabolic health markers in specific populations. Some findings suggest potential improvements in certain parameters, though results are not universal across studies. More large-scale research is needed before drawing strong conclusions.
What About NR (Nicotinamide Riboside)?
Nicotinamide riboside (NR) is another NAD+ precursor. This means it’s a form of vitamin B3 that the body converts into NAD+ through a multi-step process inside your cells.
Some studies show NR may increase blood NAD+ levels over short periods. In certain head-to-head comparisons, both NR and NMN increased circulating NAD+ after about two weeks of supplementation.
At this stage, however, there isn’t strong evidence that one is dramatically superior to the other. More human research is needed to understand differences in effectiveness and outcomes.
Which Should You Choose?
For oral supplementation, NAD+ precursors such as NMN may be more practical than NAD+ itself due to absorption considerations.
However, it’s important to keep expectations realistic. NMN is not an anti-aging cure. It also hasn’t been shown to extend human lifespan. On top of this, it’s not approved to treat or prevent any disease.
If your goal is to learn more about NAD+ biology or explore general wellness strategies related to healthy aging, NMN may be one option among several lifestyle tools.
Other evidence-based strategies that support NAD+ pathways include:
- Regular exercise
- Caloric balance
- Adequate sleep
- Metabolic health management
Supplements are just one piece of a much larger picture. It’s always important to discuss your options with a licensed healthcare provider who can determine what’s best for you and your health.
NAD IV Therapy vs. Oral NMN
Some clinics offer NAD+ IV therapy, which delivers NAD+ directly into the bloodstream.
IV administration bypasses digestive breakdown and may result in higher immediate plasma levels. However, it’s usually much more expensive, and it requires clinical supervision.
Additionally, evidence for long-term benefits remains limited. For most healthy individuals exploring general wellness support, oral precursors are more commonly used.
Quality and Third-Party Testing
Supplements aren’t regulated like prescription medications; in other words, it’s essential to do your research before purchasing any NMN supplementation.
If you’re considering NMN, look for:
- Third-party testing
- Certificate of Analysis (COA)
- Transparent purity standards
- cGMP manufacturing practices
And keep in mind that marketing claims can sometimes be just claims. NAD supplement benefits are still being explored in research and haven’t been confirmed. In other words, a supplement claiming to prevent aging or provide hard-to-believe results should set off a few red flags.
Safety Considerations
Short-term human trials (typically six to 12 weeks) have reported NMN to be well-tolerated at studied doses.
Mild side effects occasionally reported include:
- Nausea
- Headache
- Digestive discomfort
No major safety concerns have emerged in short-term studies, but long-term data are still developing. As with any supplement, individuals with medical conditions or those taking medications should speak with a licensed healthcare provider before starting.
{{primary-cta}}
NAD+ Injections Through Eden
As interest in NAD+ has grown, some people have started exploring NAD+ injections as another option.
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme naturally found in your cells. It plays a role in metabolic processes that help cells convert nutrients into energy. Because of this role in cellular biology, NAD+ has become an area of ongoing research related to metabolism and cellular health.
Through Eden, individuals can complete a brief online intake and connect with a licensed healthcare provider who reviews their health history and goals. After that evaluation, the provider may discuss different options that could be appropriate for the individual, including NAD+ injections in certain cases.
If prescribed, the medication is dispensed by a licensed pharmacy and used as directed by the provider.
Final Thoughts
Current research has more frequently examined NMN as an oral precursor compared to NAD+ itself. Because of its molecular size and charge, orally consumed NAD+ may undergo breakdown before cellular use, whereas NMN is converted to NAD+ through enzymatic steps inside cells.
But what works for one person doesn’t always work for another. Always discuss your options with a licensed healthcare provider; they can help you determine the best next step for you.

Blog Components

The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.
Eden is not a medical provider. Eden connects individuals with independent licensed healthcare providers who independently evaluate each patient to determine whether a prescription treatment program is appropriate. All prescriptions are written at the sole discretion of the licensed provider. Medications are filled by state-licensed pharmacies. Please consult a licensed healthcare provider before making any medical decisions.
Frequently asked questions
Most people don’t need both. NMN works as a precursor that your cells convert into NAD+, so taking NMN alone may raise NAD+ levels. If you’re considering combining supplements, consult a licensed healthcare provider before doing so.
Clinical studies have evaluated a range of doses, often between 250 mg and 900 mg per day. There is currently no established “optimal” dosage for aging-related purposes, and NMN is not approved to treat or prevent aging. A licensed healthcare provider can help determine what may be appropriate for you.
Blood NAD+ levels typically increase within several weeks of consistent supplementation. However, results aren’t guaranteed and may vary from person to person.
Christen, S., Redeuil, K., Goulet, L., Giner, M. P., Breton, I., Rota, R., Frézal, A., Nazari, A., Van den Abbeele, P., Godin, J. P., Nutten, S., & Cuenoud, B. (2026). The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Nature metabolism, 8(1), 62–73. https://pubmed.ncbi.nlm.nih.gov/41540253/
Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021). NAD+ metabolism and its roles in cellular processes during ageing. Nature reviews. Molecular cell biology, 22(2), 119–141. https://pmc.ncbi.nlm.nih.gov/articles/PMC7963035/
Martens, C. R., Denman, B. A., Mazzo, M. R., Armstrong, M. L., Reisdorph, N., McQueen, M. B., Chonchol, M., & Seals, D. R. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature communications, 9(1), 1286. https://pubmed.ncbi.nlm.nih.gov/29599478/
Yi, L., Maier, A. B., Tao, R., Lin, Z., Vaidya, A., Pendse, S., Thasma, S., Andhalkar, N., Avhad, G., & Kumbhar, V. (2023). The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience, 45(1), 29–43. https://pubmed.ncbi.nlm.nih.gov/36482258/
Yoshino, M., Yoshino, J., Kayser, B. D., Patti, G. J., Franczyk, M. P., Mills, K. F., Sindelar, M., Pietka, T., Patterson, B. W., Imai, S. I., & Klein, S. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science (New York, N.Y.), 372(6547), 1224–1229. https://pmc.ncbi.nlm.nih.gov/articles/PMC8550608/
Thank you!
We'll be in touch.
Thank you!




















